Burning Rock Biotech (BNR) Notes Payables (2020 - 2022)
Historic Notes Payables for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $28000.0.
- Burning Rock Biotech's Notes Payables fell 6543.21% to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $28000.0, marking a year-over-year decrease of 6543.21%. This contributed to the annual value of $81000.0 for FY2024, which is 5207.1% down from last year.
- Latest data reveals that Burning Rock Biotech reported Notes Payables of $28000.0 as of Q3 2025, which was down 6543.21% from $83000.0 recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Notes Payables registered a high of $972000.0 during Q4 2021, and its lowest value of $28000.0 during Q3 2025.
- In the last 5 years, Burning Rock Biotech's Notes Payables had a median value of $162000.0 in 2021 and averaged $191421.1.
- Per our database at Business Quant, Burning Rock Biotech's Notes Payables tumbled by 9315.88% in 2021 and then soared by 18771.93% in 2023.
- Burning Rock Biotech's Notes Payables (Quarter) stood at $972000.0 in 2021, then crashed by 73.15% to $261000.0 in 2022, then plummeted by 35.25% to $169000.0 in 2023, then tumbled by 52.07% to $81000.0 in 2024, then tumbled by 65.43% to $28000.0 in 2025.
- Its last three reported values are $28000.0 in Q3 2025, $83000.0 for Q2 2025, and $82000.0 during Q1 2025.